Healthcare > Medical Devices & Equipment
•1105 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (1105)
| Company | Market Cap | Price |
|---|---|---|
|
BRKR
Bruker Corporation
Bruker directly manufactures diagnostic instrumentation and analytical equipment such as MALDI Biotyper and other diagnostic/imaging instruments.
|
$7.44B |
$49.02
-0.63%
|
|
STVN
Stevanato Group S.p.A.
Directly manufactures Prefillable Syringes used for sterile biologic and small-molecule injections.
|
$6.94B |
$23.13
-1.07%
|
|
MIR
Mirion Technologies, Inc.
Core business: Mirion designs and manufactures medical devices and biometric sensing equipment used in radiology, radiation therapy, and nuclear medicine.
|
$6.05B |
$25.86
+1.73%
|
|
GKOS
Glaukos Corporation
Glaukos directly manufactures ophthalmology devices, including iStent MIGS implants used in eye surgeries.
|
$6.04B |
$105.44
+1.04%
|
|
GRFS
Grifols, S.A.
Gel Cards and reagent RBCs are consumables sold to diagnostics laboratories, fitting Medical Device Consumables.
|
$6.04B |
$8.78
+1.27%
|
|
IRTC
iRhythm Technologies, Inc.
Direct product: iRhythm's patch-based patient monitoring device and associated software for continuous cardiac monitoring.
|
$6.00B |
$186.59
-0.91%
|
|
BLCO
Bausch + Lomb Corporation
Ophthalmology Devices – direct manufacture and sale of eye-care surgical devices and related ophthalmic equipment.
|
$5.73B |
$16.22
+2.08%
|
|
ESE
ESCO Technologies Inc.
Diagnostic Equipment reflects ESCO's diagnostic testing instruments and related software for measurement and monitoring.
|
$5.50B |
$212.90
-2.09%
|
|
VNT
Vontier Corporation
Repair Solutions includes diagnostic equipment launches for vehicle repair workflows.
|
$5.24B |
$35.72
+0.06%
|
|
MMSI
Merit Medical Systems, Inc.
Directly tied to Merit's core cardiology/interventional devices, including cardiac intervention products and lead-management solutions (Cook acquisition).
|
$5.18B |
$87.43
-0.19%
|
|
TFX
Teleflex Incorporated
Teleflex is a global medical device company designing, manufacturing, and selling single-use medical devices across critical care, surgical, and interventional markets.
|
$5.09B |
$115.33
+0.55%
|
|
GNTX
Gentex Corporation
Medical Devices & Biometrics covers EyeLock iris biometrics and eSight medical device initiatives tied to Gentex's diversification.
|
$4.99B |
$22.73
-0.07%
|
|
TMDX
TransMedics Group, Inc.
TransMedics' Organ Care System (OCS) is a proprietary medical device platform for organ preservation and monitoring.
|
$4.97B |
$145.84
-0.11%
|
|
SHC
Sotera Health Company
Nelson Labs provides outsourced microbiological and analytical chemistry testing plus regulatory advisory services.
|
$4.95B |
$17.45
+0.46%
|
|
ALKS
Alkermes plc
Prefillable syringes as a packaging/administration technology for injectable products.
|
$4.91B |
$29.72
+2.52%
|
|
WGS
GeneDx Holdings Corp.
Laboratory testing services and advisory components of genetic diagnostics.
|
$4.76B |
$165.51
-1.19%
|
|
OSIS
OSI Systems, Inc.
Patient Monitoring represents next-generation monitoring platforms and solutions within healthcare offerings.
|
$4.57B |
$271.56
+1.59%
|
|
NOVT
Novanta Inc.
Medical Devices & Biometrics aligning with their focus on medical devices and biometric sensing technologies.
|
$4.06B |
$113.00
+0.99%
|
|
LNTH
Lantheus Holdings, Inc.
Liquid imaging agents (PET tracers and ultrasound contrast) place the company squarely in medical imaging as a core business.
|
$3.99B |
$58.73
-0.57%
|
|
GRAL
GRAIL, Inc.
Galleri is a liquid biopsy-based multi-cancer early detection test using cfDNA methylation, the core product.
|
$3.97B |
$111.20
+3.26%
|
|
AMRX
Amneal Pharmaceuticals, Inc.
DHE autoinjector (Brekiya) approval signals involvement in auto-injector device delivery systems.
|
$3.93B |
$12.53
+0.68%
|
|
HAE
Haemonetics Corporation
Haemonetics manufactures medical devices and biometrics for hospital blood management and plasma processing.
|
$3.89B |
$80.67
+0.04%
|
|
PLXS
Plexus Corp.
Healthcare/Life Sciences end-market, with Plexus serving medical devices and related equipment through its engineering and manufacturing services.
|
$3.88B |
$144.21
+1.12%
|
|
INSP
Inspire Medical Systems, Inc.
Inspire V is a neuromodulation device designed to treat obstructive sleep apnea, representing Inspire's core product category.
|
$3.77B |
$127.50
-2.22%
|
|
VCYT
Veracyte, Inc.
The company offers MRD and other liquid biopsy tests, placing it in the liquid biopsy space.
|
$3.75B |
$47.77
-3.26%
|
|
ICUI
ICU Medical, Inc.
Medical Device Consumables includes disposable items used with infusion therapy (Clave connectors, ChemoLock/ChemoClave CSTDs) and is a core revenue stream.
|
$3.68B |
$149.32
-1.70%
|
|
NVST
Envista Holdings Corp
Envista directly manufactures dental equipment, including implants and aligners, a core product line.
|
$3.49B |
$20.98
-0.31%
|
|
LIVN
LivaNova PLC
Directly manufactures/distributes Neuromodulation Devices, including VNS Therapy and proximal hypoglossal nerve stimulation systems.
|
$3.49B |
$63.78
+0.74%
|
|
ATEC
Alphatec Holdings, Inc.
Alphatec's primary business is spine/orthopedic implants and devices.
|
$3.34B |
$22.61
+3.55%
|
|
IPGP
IPG Photonics Corporation
IPG markets medical laser systems including thulium lasers for urology, fitting Medical Devices & Biometrics.
|
$3.31B |
$78.60
+1.28%
|
|
ADPT
Adaptive Biotechnologies Corporation
ADPT directly provides clonoSEQ MRD diagnostic testing and related laboratory services.
|
$3.00B |
$19.73
-2.93%
|
|
SXI
Standex International Corporation
Medical devices & biometrics/public healthcare equipment segment exposure.
|
$2.94B |
$243.50
+0.49%
|
|
LQDA
Liquidia Corporation
YUTREPIA includes a dry-powder inhaler device component, aligning with medical devices and equipment category.
|
$2.73B |
$31.72
-1.67%
|
|
CON
Concentra Group Holdings Parent, Inc.
Laboratory testing & advisory services are part of the occupational health testing offerings and regulatory/compliance support seen in the business model.
|
$2.67B |
$20.86
-1.39%
|
|
ITGR
Integer Holdings Corporation
Cardiology devices market, including rhythm management and electrophysiology, is a core high-growth market referenced in the strategy.
|
$2.52B |
$72.09
+0.92%
|
Showing page 3 of 12 (1105 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
